Abstract
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) plays an essential role in T cell homeostasis by restraining immune responses. AG and GG genotypes of donor CTLA-4 SNP rs4553808 in patients after unrelated donor hematopoietic stem cell transplantations (HSCT) have been shown to be an independent predictor of inferior relapse-free survival (RFS) and overall survival (OS) compared with those with the AA genotype, in single-center studies. We tested the hypothesis that SNP rs4553808 is associated with RFS, OS, nonrelapse mortality (NRM) and the cumulative incidence of acute graft-versus-host disease (GVHD) and chronic GVHD in adults with acute myeloid leukemia and advanced myelodysplastic syndrome undergoing a first 8/8 or 7/8 HLA-matched unrelated donor HSCT. Multivariable analysis adjusting for relevant donor and recipient characteristics showed no significant association between SNP rs4553808 and OS, RFS, NRM, and incidence of acute and chronic GVHD. An exploratory analysis of other CTLA-4 SNPs, as well as studying the interaction with antithymocyte globulin, also demonstrated no significant associations. Our results indicate that CTLA-4 SNPs are not associated with HSCT outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 900-903 |
Number of pages | 4 |
Journal | Biology of Blood and Marrow Transplantation |
Volume | 20 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2014 |
Bibliographical note
Funding Information:The authors acknowledge Cara Sutcliffe, MS Center for Human Genetics Research and Heidi Chen, PhD, Department of Biostatistics for their assistance with this study. Authorship statement : All authors listed participated in the design of the study and the writing of this manuscript. Financial disclosure: This study was supported in part by research funding from Sanofi-Oncology to S.S. and M.J.
Keywords
- Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
- Hematopoietic stem cell transplantation
- Single nucleotide polymorphisms (SNPs)